Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 80 results.
User Information
Export Records
  1. 1.   Multiple Endocrine Neoplasia Type 2B Presents Early in Childhood but Often Is Undiagnosed for Years
  2. Makri, Angeliki; Akshintala, Srivandana; Derse-Anthony, Claudia; Widemann, Brigitte; Stratakis, Constantine A.; Glod, John; Lodish, Maya
  3. JOURNAL OF PEDIATRICS. 2018, DEC; 203: 447-449.
  1. 2.   Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib
  2. Kraft, Ira L.; Akshintala, Srivandana; Zhu, Yuelin; Lei, Haiyan; Derse-Anthony, Claudia; Dombi, Eva; Steinberg, Seth M.; Lodish, Maya; Waguespack, Steven G.; Kapustina, Oxana; Fox, Elizabeth; Balis, Frank M.; Merino, Maria J.; Meltzer, Paul S.; Glod, John W.; Shern, Jack F.; Widemann, Brigitte C.
  3. CLINICAL CANCER RESEARCH. 2018, Feb 15; 24(4): 753-765.
  1. 3.   Truncation of Histone H2A's C-terminal Tail, as Is Typical for Ni(II)-Assisted Specific Peptide Bond Hydrolysis, Has Gene Expression Altering Effects
  2. Karaczyn, A. A.; Cheng, R.; Buzard, G. S.; Hartley, J.; Esposito, D.; Kasprzak, K. S.
  3. Annals of Clinical and Laboratory Science. 2009 39(3): 251-262.
  1. 4.   Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma
  2. Berndt, S. I.; Huang, W. Y.; Chatterjee, N.; Yeager, M.; Welch, R.; Chanock, S. J.; Weissfeld, J. L.; Schoen, R. E.; Hayes, R. B.
  3. Carcinogenesis. 2007, Sep; 28(9): 1965-1970.
  1. 5.   Expression of hypoxia inducible factor-1 alpha and 2 alpha in genetically distinct early renal cortical tumors
  2. Kim, C. M.; Vocke, C.; Torres-Cabala, C.; Yang, Y. F.; Schmidt, L.; Walther, M.; Linehan, W. M.
  3. Journal of Urology. 2006, May; 175(5): 1908-1914.
  1. 6.   A threshold requirement for Gbx2 levels in hindbrain development
  2. Waters, S. T.; Lewandoski, M.
  3. Development. 2006, May; 133(10): 1991-2000.
  1. 7.   High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dube-associated renal tumors
  2. Vocke, C. D.; Yang, Y. F.; Pavlovich, C. P.; Schmidt, L. S.; Nickerson, M. L.; Torres-Cabala, C. A.; Merino, M. J.; Walther, M. M.; Zbar, B.; Linehan, W. M.
  3. Journal of the National Cancer Institute. 2005, JUN 15; 97(12): 931-935.
  1. 8.   Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation
  2. Puppo, M.; Pastorino, S.; Melillo, G.; Pezzolo, A.; Varesio, L.; Bosco, M. C.
  3. Clinical Cancer Research. 2004, DEC 15; 10(24): 8704-8719.
  1. 9.   Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele
  2. Graveel, C.; Su, Y. L.; Koeman, J.; Wang, L. M.; Tessarollo, L.; Fiscella, M.; Birchmeier, C.; Swiatek, P.; Bronson, R.; Woude, G. V.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004, DEC 7; 101(49): 17198-17203.
  1. 10.   BCL-3 and NF-kappa B p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages
  2. Wessells, J.; Baer, M.; Young, H. A.; Claudio, E.; Brown, K.; Siebenlist, U.; Johnson, P. F.
  3. Journal of Biological Chemistry. 2004, NOV 26; 279(48): 49995-50003.
  1. 11.   Induction of stem cell factor/c-Kit/Slug signal transduction in multidrug-resistant malignant mesothelioma cells
  2. Catalano, A.; Rodilossi, S.; Rippo, M. R.; Caprari, P.; Procopio, A.
  3. Journal of Biological Chemistry. 2004, NOV 5; 279(45): 46706-46714.
  1. 12.   Early onset hereditary papillary renal carcinoma: Germline missense mutations in the tyrosine kinase domain of the met proto-oncogene
  2. Schmidt, L. S.; Nickerson, M. L.; Angeloni, D.; Glenn, G. M.; Walther, M. M.; Albert, P. S.; Warren, M. B.; Choyke, P. L.; Torres-Cabala, C. A.; Merino, M. J.; Brunet, J.; Berez, V.; Borras, J.; Sesia, G.; Middelton, L.; Phillips, J. L.; Stolle, C.; Zbar, B.; Pautler, S. E.; Linehan, W. M.
  3. Journal of Urology. 2004, OCT; 172(4): 1256-1261.
  1. 13.   Genetic basis of cancer of the kidney: Disease specific approaches to therapy
  2. Linehan, W. M.; Vasselli, J.; Srinivasan, R.; Walther, M. M.; Merino, M.; Choyke, P.; Vocke, C.; Schmidt, L.; Isaacs, J. S.; Glenn, G.; Toro, J.; Zbar, B.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2004, SEP 15; 10(18, Part 2 Suppl. S): 6282S-6289S.
  1. 14.   Mapping and characterization of the minimal internal ribosome entry segment in the human c-myc mRNA 5 ' untranslated region
  2. Cencig, S.; Nanbru, C.; Le, S. Y.; Gueydan, C.; Huez, G.; Kruys, V.
  3. Oncogene. 2004 23(1): 267-277.
  1. 15.   Unlocking the code of 14-3-3
  2. Dougherty, M. K.; Morrison, D. K.
  3. Journal of Cell Science. 2004 117(10): 1875-1884.
  1. 16.   Hematopoietic, angiogenic and eye defects in Meis1 mutant animals
  2. Hisa, T.; Spence, S. E.; Rachel, R. A.; Fujita, M.; Nakamura, T.; Ward, J. M.; Devor-Henneman, D. E.; Saiki, Y.; Kutsuna, H.; Tessarollo, L.; Jenkins, N. A.; Copeland, N. G.
  3. Embo Journal. 2004 23(2): 450-459.
  1. 17.   Phosphatidylinositol 3 '-kinase is required for growth of mast cells expressing the Kit catalytic domain mutant
  2. Shivakrupa, R.; Bernstein, A.; Watring, N.; Linnekin, D.
  3. Cancer Research. 2003 63(15): 4412-4419.
  1. 18.   Quantifying cell scattering: The blob algorithm revisited
  2. Kort, E. J.; Jones, A.; Daumbach, M.; Hudson, E. A.; Buckner, B.; Resau, J. H.
  3. Cytometry Part A. 2003 51A(2): 119-126.
  1. 19.   Studying cancer families to identify kidney cancer genes
  2. Zbar, B.; Klausner, R.; Linehan, W. M.
  3. Annual Review of Medicine-Selected Topics in the Clinical Sciences. 2003 54: 217-233.
  1. 20.   The genetic basis of renal cell carcinoma
  2. Pavlovich, C. P.; Schmidt, L. S.; Phillips, J. L.
  3. Urologic Clinics of North America. 2003 30(3): 437-+.
  1. 21.   Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome
  2. Nickerson, M. L.; Warren, M. B.; Toro, J. R.; Matrosova, V.; Glenn, G.; Turner, M. L.; Duray, P.; Merino, M.; Choyke, P.; Pavlovich, C. P.; Sharma, N.; Walther, M.; Munroe, D.; Hill, R.; Maher, E.; Greenberg, C.; Lerman, M. I.; Linehan, W. M.; Zbar, B.; Schmidt, L. S.
  3. Cancer Cell. 2002 2(2): 157-164.
  1. 22.   New genes involved in cancer identified by retroviral tagging
  2. Suzuki, T.; Shen, H. F.; Akagi, K.; Morse, H. C.; Malley, J. D.; Naiman, D. Q.; Jenkins, N. A.; Copeland, N. G.
  3. Nature Genetics. 2002 32(1): 166-174.
  1. 23.   Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
  2. Danilkovitch-Miagkova, A.; Zbar, B.
  3. Journal of Clinical Investigation. 2002 109(7): 863-867.
  1. 24.   Random mutagenesis-PCR to introduce alterations into defined DNA sequences for validation of SNP and mutation detection methods
  2. Nickerson, M. L.; Warren, M. B.; Zbar, B.; Schmidt, L. S.
  3. Human Mutation. 2001 17(3): 210-219.
  1. 25.   Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models
  2. Cao, B.; Su, Y. L.; Oskarsson, M.; Zhao, P.; Kort, E. J.; Fisher, R. J.; Wang, L. M.; Vande Woude, G. F.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2001 98(13): 7443-7448.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel